US 7,608,597 B2
	Methods and compositions for treating hepatitis C virus
Jean-Pierre Sommadossi, Birmingham, Ala. (US); and Paulo LaColla, Cagliari (Israel)
Assigned to Idenix Pharmaceuticals, Inc., Cambridge, Mass. (US); and Universita Degli Studi Di Cagliari, Cagliari (Italy)
Filed on Jun. 20, 2003, as Appl. No. 10/602,691.
Application 10/602691 is a continuation of application No. 09/864078, filed on May 23, 2001, granted, now 6,914,054.
Claims priority of provisional application 60/206585, filed on May 23, 2000.
Prior Publication US 2004/0097461 A1, May 20, 2004
Int. Cl. A01N 43/04 (2006.01); A61K 31/70 (2006.01)

U.S. Cl. 514—42  [514/43; 514/44; 514/45; 514/46; 514/47; 514/48; 514/49; 514/50; 514/51]

33 Claims

1. A method for the treatment of a hepatitis C virus infection, comprising administering an effective amount of a purine or pyrimidine β-D-2′-methyl-ribofuranosyl nucleoside or a phosphate thereof, or a pharmaceutically acceptable salt or ester thereof.